Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cust AE"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 42
Tytuł:
Implementing systematic melanoma risk assessment and risk-tailored surveillance in a skin cancer focussed dermatology clinic: A qualitative study of feasibility and acceptability to patients and clinic staff.
Autorzy:
Smith AL; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
Smit AK; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Laginha BI; Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
Singh N; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
Gallo B; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Martin L; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
Cust AE; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Jan; Vol. 13 (2), pp. e6976.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/diagnosis
Melanoma*/epidemiology
Dermatology*
Skin Neoplasms*/diagnosis
Skin Neoplasms*/epidemiology
Humans ; Feasibility Studies ; Prospective Studies ; Risk Assessment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acceptability and appropriateness of a risk-tailored organised melanoma screening program: Qualitative interviews with key informants.
Autorzy:
Dunlop KLA; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Keogh LA; Centre for Health Equity, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
Smith AL; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.
Aranda S; School of Health Sciences, University of Melbourne, Melbourne, Australia.
Aitken J; Viertel Cancer Research Centre, Cancer Council Queensland, Brisbane, Queensland, Australia.
Watts CG; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.; Surveillance, Evaluation & Research Program, Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Smit AK; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Janda M; Centre for Health Services Research, The University of Queensland, St Lucia, Queensland, Australia.
Mann GJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; John Curtin School of Medical Research, Australian National University, Acton, Australian Capital Territory, Australia.; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales, Australia.
Cust AE; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Rankin NM; Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 13; Vol. 18 (12), pp. e0287591. Date of Electronic Publication: 2023 Dec 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/diagnosis
Melanoma*/prevention & control
Humans ; Health Care Costs ; Health Personnel ; Emotions ; Mass Screening ; Qualitative Research
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sex-Specific Associations of MDM2 and MDM4 Variants with Risk of Multiple Primary Melanomas and Melanoma Survival in Non-Hispanic Whites.
Autorzy:
Ward SV; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; School of Population and Global Health, The University of Western Australia, Perth, WA 6009, Australia.
Autuori I; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Luo L; Department of Internal Medicine, The University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87106, USA.
LaPilla E; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Yoo S; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sharma A; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Busam KJ; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Olilla DW; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA.
Dwyer T; Clinical Sciences Theme, Heart Group, Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia.; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Carlton, VIC 3010, Australia.; Oxford Martin School, University of Oxford, Oxford OX1 3BD, UK.; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia.
Anton-Culver H; Department of Medicine, University of California, Irvine, CA 92617, USA.
Zanetti R; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10126 Turin, Italy.
Sacchetto L; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10126 Turin, Italy.
Cust AE; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW 2006, Australia.; Melanoma Institute Australia, The University of Sydney, Wollstonecraft, NSW 2065, Australia.
Gallagher RP; BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC V5Z 4E8, Canada.
Kanetsky PA; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Rosso S; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10126 Turin, Italy.
Begg CB; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Berwick M; Department of Internal Medicine, The University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87106, USA.
Thomas NE; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA.; Department of Dermatology, University of North Carolina, Chapel Hill, NC 27514, USA.
Orlow I; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Pokaż więcej
Corporate Authors:
GEM Study Group
Źródło:
Cancers [Cancers (Basel)] 2023 May 11; Vol. 15 (10). Date of Electronic Publication: 2023 May 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.
Autorzy:
Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Sadeghi KD; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Edmiston SN; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Kenney JM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Lezcano C; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
Cust AE; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; The Daffodil Centre, University of Sydney, a joint venture with Cancer Council New South Wales, Australia.; Sydney School of Public Health, The University of Sydney, Sydney, Australia.
Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
Mann GJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.; John Curtin School of Medical Research, Australian National University, Canberra, Australia.
Lee TK; British Columbia Cancer Research Center, Vancouver, British Columbia, Canada.
Burke H; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Jakrot V; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Shang P; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and New South Wales Health Pathology, Sydney, New South Wales, Australia.
Boyce TW; Department of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States of America.
Ko JS; Department of Pathology, Cleveland Clinic, Cleveland, Ohio, United States of America.
Ngo P; Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio, United States of America.
Funchain P; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
Rees JR; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America.
O'Connell K; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Hao H; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Parrish E; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Conway K; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Googe PB; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Ollila DW; Department of Surgery, Division of Surgical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Moschos SJ; Department of Medicine, Division of Medical Oncology, The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America.
Hernando E; Department of Pathology, New York University Grossman School of Medicine, New York, New York, United States of America.
Hanniford D; Department of Pathology, New York University Grossman School of Medicine, New York, New York, United States of America.
Argibay D; Department of Pathology, New York University Grossman School of Medicine, New York, New York, United States of America.
Amos CI; Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
Lee JE; Department of Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America.
Osman I; Department of Urology, New York University Grossman School of Medicine, New York, NY, United States of America.; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America.; Department of Dermatology, New York University Grossman School of Medicine, New York, NY, United States of America.
Luo L; Department of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States of America.
Kuan PF; Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, New York, United States of America.
Aurora A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Gould Rothberg BE; Smilow Cancer Hospital, Yale-New Haven Health System, New Haven, Connecticut, United States of America.
Bosenberg MW; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut, United States of America.; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, United States of America.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, United States of America.; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America.
Gerstenblith MR; Department of Dermatology, University Hospitals Cleveland Medical Center/Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Thompson C; Department of Nutrition, Case Western Reserve University, Cleveland, Ohio, United States of America.; Department of Public Health Sciences, Penn State University College of Medicine, Hershey, Pennsylvania, United States of America.
Bogner PN; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States of America.
Gorlov IP; Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
Holmen SL; Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, Utah, United States of America.; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah, United States of America.; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah, United States of America.
Brunsgaard EK; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah, United States of America.
Saenger YM; Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York, United States of America.; Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Shen R; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Seshan V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Nagore E; Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain.
Ernstoff MS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, ImmunoOncology Branch, Developmental Therapeutics Program, Rockville, Maryland, United States of America.
Busam KJ; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Begg CB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Thomas NE; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Berwick M; Department of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States of America.
Pokaż więcej
Corporate Authors:
InterMEL Consortium
Źródło:
PloS one [PLoS One] 2023 Apr 03; Vol. 18 (4), pp. e0269324. Date of Electronic Publication: 2023 Apr 03 (Print Publication: 2023).
Typ publikacji:
Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
MicroRNAs*/analysis
Melanoma*/genetics
Nucleic Acids*
Humans ; Tissue Fixation/methods ; DNA/genetics ; Paraffin Embedding/methods ; Formaldehyde
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Study protocol for a randomised controlled trial to evaluate the use of melanoma surveillance photography to the Improve early detection of MelanomA in ultra-hiGh and high-risk patiEnts (the IMAGE trial).
Autorzy:
Yan MK; School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia. .; Victorian Melanoma Service, Alfred Hospital, Melbourne, VIC, Australia. .
Cust AE; The Daffodil Centre, The University of Sydney, a Joint Venture With Cancer Council NSW, Sydney, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Soyer HP; Dermatology Research Centre, The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, QLD, Australia.; Dermatology Department, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
Janda M; Centre for Health Services Research, The University of Queensland, Brisbane, QLD, Australia.
Loewe K; Melanoma and Skin Cancer Research Centre, Monash University, Melbourne, VIC, Australia.
Byars G; Melanoma and Skin Cancer Research Centre, Monash University, Melbourne, VIC, Australia.
Fishburn P; Norwest Skin Cancer Centre, Bella Vista, New South Wales, Australia.
White P; Melanoma and Skin Cancer Research Centre, Monash University, Melbourne, VIC, Australia.
Mahumud RA; NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.
Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Herschtal A; School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.
Fernandez-Penas P; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Guitera P; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Morton RL; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Kelly J; Victorian Melanoma Service, Alfred Hospital, Melbourne, VIC, Australia.
Wolfe R; School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.
Mar VJ; School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.; Victorian Melanoma Service, Alfred Hospital, Melbourne, VIC, Australia.
Pokaż więcej
Źródło:
Trials [Trials] 2023 Mar 29; Vol. 24 (1), pp. 236. Date of Electronic Publication: 2023 Mar 29.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Melanoma*/diagnostic imaging
Skin Neoplasms*/diagnostic imaging
Humans ; Early Detection of Cancer ; Photography ; Victoria ; Cost-Benefit Analysis ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Reflectance confocal microscopy in Australia: Perspectives on barriers to implementation and uptake.
Autorzy:
Ho G; Melanoma Institute Australia, The University of Sydney, North Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Australia.; Faculty of Medicine, University of New South Wales, New South Wales, Sydney, Australia.
Smith A; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
Cust AE; Melanoma Institute Australia, The University of Sydney, North Sydney, New South Wales, Australia.; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
Melhoranse-Gouveia B; Melanoma Institute Australia, The University of Sydney, North Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Australia.
Collgros H; Faculty of Medicine and Health, University of Sydney, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, New South Wales, Sydney, Australia.
Martin L; Melanoma Institute Australia, The University of Sydney, North Sydney, New South Wales, Australia.; Faculty of Medicine, University of New South Wales, New South Wales, Sydney, Australia.
Guitera P; Melanoma Institute Australia, The University of Sydney, North Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, New South Wales, Sydney, Australia.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2023 Feb; Vol. 64 (1), pp. e109-e111. Date of Electronic Publication: 2022 Nov 22.
Typ publikacji:
Letter
MeSH Terms:
Skin Neoplasms*
Melanoma*
Humans ; Microscopy, Confocal ; Australia
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.
Autorzy:
Luo L; Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA.
Shen R; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Arora A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Incyte, Wilmington, Delaware, USA.
Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Busam KJ; Department of Pathology and Laboratory Science, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Lezcano C; Department of Pathology and Laboratory Science, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Lee TK; British Columbia Cancer Research Center, Vancouver, British Columbia, Canada.
Hernando E; Langone Cancer Center, New York University, New York, New York, USA.
Gorlov I; Epidemiology and Population Science, Baylor Medical Center, Houston, Texas, USA.
Amos C; Epidemiology and Population Science, Baylor Medical Center, Houston, Texas, USA.
Ernstoff MS; ImmunoOncology Branch, National Cancer Institute, Rockville, Maryland, USA.
Seshan VE; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Cust AE; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Wilmott J; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.
Scolyer RA; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
Mann G; John Curtin School of Medical Research, Australian National University, Acton, Australian Capital Territory, Australia.
Nagore E; Instituto de Oncologia, Valencia, Spain.
Funchain P; Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Ko J; Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Ngo P; Cleveland Clinic Foundation, Cleveland, Ohio, USA.; Department of Hospice and Palliative Care, University of South Florida, Tampa, Florida, USA.
Edmiston SN; Department of Dermatology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Conway K; Department of Dermatology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Googe PB; Department of Dermatology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Ollila D; Department of Dermatology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Lee JE; The University of Texas MDAnderson Cancer Center, Houston, Texas, USA.
Fang S; The University of Texas MDAnderson Cancer Center, Houston, Texas, USA.
Rees JR; Dartmouth Cancer Center, Lebanon, New Hampshire, USA.
Thompson CL; Case Western Reserve University, Cleveland, Ohio, USA.; Penn State University, Hershey, Pennsylvania, USA.
Gerstenblith M; Case Western Reserve University, Cleveland, Ohio, USA.
Bosenberg M; Department of Pathology, Yale University, New Haven, Connecticut, USA.
Gould Rothberg B; Department of Pathology, Yale University, New Haven, Connecticut, USA.
Osman I; Langone Cancer Center, New York University, New York, New York, USA.
Saenger Y; Columbia University Medical School, New York, New York, USA.; Albert Einstein School of Medicine, New York, New York, USA.
Reynolds AZ; Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA.
Schwartz M; Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA.
Boyce T; Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA.
Holmen S; Huntsman Cancer Center, University of Utah, Salt Lake City, Utah, USA.
Brunsgaard E; Huntsman Cancer Center, University of Utah, Salt Lake City, Utah, USA.
Bogner P; Departments of Pathology and Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Kuan PF; Stony Brook University, Stony Brook, New York, USA.
Wiggins C; Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA.
Thomas NE; Department of Dermatology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Begg CB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Berwick M; Department of Internal Medicine and the UNM Comprehensive Cancer Center, Albuquerque, New Mexico, USA.
Pokaż więcej
Corporate Authors:
InterMEL
Źródło:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2022 Nov; Vol. 35 (6), pp. 605-612. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma*/pathology
Skin Neoplasms*/drug therapy
MicroRNAs*
Humans ; Male ; Aged ; Female ; Proto-Oncogene Proteins B-raf/genetics ; Mutation/genetics ; Melanoma, Cutaneous Malignant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sensitivity of two Australian melanoma risk tools to identify high-risk individuals among people presenting with their first primary melanoma.
Autorzy:
Tan K; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Cust AE; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia.
Wolfe R; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Mar V; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Victorian Melanoma Service, Alfred Health, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2022 Aug; Vol. 63 (3), pp. 352-358. Date of Electronic Publication: 2022 May 06.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/diagnosis
Melanoma*/epidemiology
Melanoma*/pathology
Skin Neoplasms*/diagnosis
Skin Neoplasms*/pathology
Australia/epidemiology ; Humans ; Male ; Neoplasm Invasiveness ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study.
Autorzy:
Davari DR; Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA.
Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Kanetsky PA; Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Luo L; Department of Internal Medicine, University of New Mexico Cancer Center, University of New Mexico, Albuquerque, NM 87102, USA.
Busam KJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sharma A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Kricker A; Sydney School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia.
Cust AE; Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, NSW 2006, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia.
Anton-Culver H; Department of Medicine, University of California, Irvine, CA 92697, USA.
Gruber SB; City of Hope National Medical Center, Duarte, CA 91010, USA.
Gallagher RP; BC Cancer and Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC V5Z 1L3, Canada.
Zanetti R; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10156 Turin, Italy.
Rosso S; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10156 Turin, Italy.
Sacchetto L; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10156 Turin, Italy.
Dwyer T; Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia.; The Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Department of Pediatrics, University of Melbourne, Melbourne, VIC 3010, Australia.; Oxford Martin School, University of Oxford, Oxford OX1 3BD, UK.
Gibbs DC; School of Medicine, Emory University, Atlanta, GA 30322, USA.
Ollila DW; Department of Surgery, University of North Carolina, Chapel Hill, NC 27599, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Begg CB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Berwick M; Department of Internal Medicine, University of New Mexico Cancer Center, University of New Mexico, Albuquerque, NM 87102, USA.
Thomas NE; Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Nov 16; Vol. 28 (6), pp. 4756-4771. Date of Electronic Publication: 2021 Nov 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma*/genetics
Melanoma*/pathology
Skin Neoplasms*/genetics
Skin Neoplasms*/pathology
Genome-Wide Association Study ; Humans ; Lymphocytes, Tumor-Infiltrating/pathology ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Surveillance of patients with thin melanoma.
Autorzy:
Ribero S; Dermatology Clinic, University of Turin, Turin, Italy.
Cust AE; Faculty of Medicine and Health and Melanoma Institute of Australia, The University of Sydney, Camperdown, New South Wales, Australia.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2021 Nov; Vol. 62 (4), pp. 530-532. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji:
Letter
MeSH Terms:
Aftercare*
Melanoma/*diagnosis
Skin Neoplasms/*diagnosis
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Acceptability of risk-stratified population screening across cancer types: Qualitative interviews with the Australian public.
Autorzy:
Dunlop K; Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Rankin NM; Sydney School of Public Health, The Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Smit AK; Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Salgado Z; Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.
Newson AJ; Sydney Health Ethics, Sydney School of Public Health, The Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Keogh L; Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Cust AE; Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Pokaż więcej
Źródło:
Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2021 Aug; Vol. 24 (4), pp. 1326-1336. Date of Electronic Publication: 2021 May 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Early Detection of Cancer*
Neoplasms*/diagnosis
Australia ; Genomics ; Humans ; Mass Screening
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diagnostic tools used for melanoma: A survey of Australian general practitioners and dermatologists.
Autorzy:
Nguyen J; Victorian Melanoma Service, Alfred Health, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Ting S; Victorian Melanoma Service, Alfred Health, Melbourne, Victoria, Australia.; The Royal Australian College of General Practitioners, East Melbourne, Victoria, Australia.
Paul E; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Smith AL; Macquarie University, Sydney, New South Wales, Australia.
Watts CG; The Sydney School of Public Health and Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Kirby Institute, UNSW, Sydney, New South Wales, Australia.
Kelly J; The Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Cust AE; The Sydney School of Public Health and Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Mar V; Victorian Melanoma Service, Alfred Health, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2021 Aug; Vol. 62 (3), pp. 300-309. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji:
Journal Article
MeSH Terms:
Dermoscopy/*statistics & numerical data
Melanoma/*diagnosis
Practice Patterns, Physicians'/*standards
Skin Neoplasms/*diagnosis
Australia ; Dermatologists ; Humans ; Physical Examination/standards
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial.
Autorzy:
Ackermann DM; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Smit AK; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
Janda M; Centre for Health Services Research, The University of Queensland, Brisbane, Australia.
van Kemenade CH; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Dieng M; NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia.
Morton RL; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia.
Turner RM; Biostatistics Centre, University of Otago, Dunedin, New Zealand.
Cust AE; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
Irwig L; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Hersch JK; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Guitera P; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, Australia.
Soyer HP; Dermatology Research Centre, The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, Australia.; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia.
Mar V; Victorian Melanoma Service, Alfred Health, Melbourne, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Division of Surgery, Royal Prince Alfred Hospital, Sydney, Australia.
Low D; Cancer Voices NSW, Sydney, Australia.
Low C; Cancer Voices NSW, Sydney, Australia.
Drabarek D; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Espinoza D; NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia.
Emery J; Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
Murchie P; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Division of Surgery, Royal Prince Alfred Hospital, Sydney, Australia.
Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, Australia.
Azzi A; Newcastle Skin Check, Newcastle, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Australia.
Lilleyman A; Newcastle Skin Check, Newcastle, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Australia.
Bell KJL; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. .
Pokaż więcej
Źródło:
Trials [Trials] 2021 May 04; Vol. 22 (1), pp. 324. Date of Electronic Publication: 2021 May 04.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Melanoma*/diagnosis
Skin Neoplasms*/diagnosis
Australia ; Follow-Up Studies ; Humans ; Randomized Controlled Trials as Topic ; Self-Examination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study.
Autorzy:
Smith AL; Australian Institute of Health Innovation, Macquarie University, Sydney, NSW, Australia.; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.
Watts CG; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.; Surveillance, Epidemiology and Prevention Program, Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Robinson S; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.
Schmid H; Centre for Cancer Research, Westmead Institute for Medical Research, Sydney, NSW, Australia.
Goumas C; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.
Mar VJ; Victorian Melanoma Service, The Alfred Hospital, Melbourne, VIC, Australia.
Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; The Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Mater Hospital, Sydney, NSW, Australia.
Rapport F; Australian Institute of Health Innovation, Macquarie University, Sydney, NSW, Australia.
Cust AE; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
Pokaż więcej
Corporate Authors:
Australian Melanoma Centre of Research Excellence Study Group
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2021 May; Vol. 62 (2), pp. 168-176. Date of Electronic Publication: 2020 Dec 05.
Typ publikacji:
Journal Article
MeSH Terms:
Attitude of Health Personnel*
Clinical Competence*
Dermatologists*
Sentinel Lymph Node Biopsy*
Melanoma/*pathology
Skin Neoplasms/*pathology
Adult ; Aged ; Australia ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families.
Autorzy:
Lacson JCA; Department of Cancer Epidemiology, Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Dr., MRC 213, Tampa, FL, 33612, USA.
Zamani SA; Department of Cancer Epidemiology, Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Dr., MRC 213, Tampa, FL, 33612, USA.; Medical Research Council - Cancer Unit, Division of Clinical Medicine, University of Cambridge, Cambridge, Cambridgeshire, UK.
Froes LAR Jr; Department of Pathology, School of Medicine, Universidade de São Paulo (USP), São Paulo, SP, Brazil.
Mitra N; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Qian L; SWOG Statistics and Data Management Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Doyle SH; Department of Cancer Epidemiology, Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Dr., MRC 213, Tampa, FL, 33612, USA.
Azizi E; Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Balestrini C; Servicio de Dermatología, Hospital Dr. Sótero del Río, Santiago de Chile, Chile.
Bishop DT; Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Bruno W; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
Carlos-Ortega B; Departamento de Ciencias Básicas, Escuela de Medicina Universidad de Monterrey, Monterrey, Mexico.
Cuellar F; Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions biomediques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.; Consejo Nacional de Ciencia y Tecnología (CONACYT), Ciudad de México, Mexico.
Cust AE; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Wollstonecraft, New South Wales, Australia.
Elder DE; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Gerdes AM; Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark.
Ghiorzo P; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.; Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Grazziotin TC; Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
Gruis NA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
Hansson J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Hočevar M; Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Höiom V; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Holland EA; Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.
Ingvar C; Departments of Clinical Sciences and Surgery, Lund University Hospital, Lund, Sweden.
Landman G; Department of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil.; Department of Pathology, AC Camargo Cancer Center, São Paulo, Brazil.
Larre-Borges A; Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay.
Mann GJ; Melanoma Institute Australia, The University of Sydney, Wollstonecraft, New South Wales, Australia.; Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
Molgo M; Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
Moredo LF; Skin Cancer Department, AC Camargo Cancer Center, São Paulo, Brazil.
Olsson H; Departments of Clinical Sciences and Surgery, Lund University Hospital, Lund, Sweden.
Out-Luiting JJ; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
Perić B; Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Pjanova D; Latvian Biomedical Research and Study Centre, Riga, Latvia.
Puig S; Melanoma Unit, Dermatology Department, Hospital Clinic Barcelona, Institut de Investigacions biomediques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain.; Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.
Salas-Alanis J; Departamento de Ciencias Básicas, Escuela de Medicina Universidad de Monterrey, Monterrey, Mexico.; Dystrophic Epidermolysis Bullous Research Association Mexico, Monterrey, Mexico.
Schmid H; Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.
Wadt KAW; Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark.
Newton-Bishop JA; Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Kanetsky PA; Department of Cancer Epidemiology, Division of Population Science, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Dr., MRC 213, Tampa, FL, 33612, USA. .
Pokaż więcej
Corporate Authors:
GenoMEL Study Group
Źródło:
BMC public health [BMC Public Health] 2021 Apr 23; Vol. 21 (1), pp. 692. Date of Electronic Publication: 2021 Apr 23.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/epidemiology
Melanoma*/prevention & control
Skin Neoplasms*/epidemiology
Skin Neoplasms*/prevention & control
Sunburn*/epidemiology
Sunburn*/prevention & control
Humans ; Retrospective Studies ; Sunscreening Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.
Autorzy:
Lo SN; The University of Sydney, Melanoma Institute Australia, Sydney, NSW, Australia.
Smit AK; The University of Sydney, Melanoma Institute Australia, Sydney, NSW, Australia.; The University of Sydney, Faculty of Medicine and Health, Sydney School of Public Health, Cancer Epidemiology and Prevention Research, Sydney, NSW, Australia.; The University of Sydney, Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, Sydney, NSW, Australia.
Espinoza D; The University of Sydney, NHMRC Clinical Trials Centre, Sydney, NSW, Australia.
Cust AE; The University of Sydney, Melanoma Institute Australia, Sydney, NSW, Australia. anne.cust@sydney.edu.au.; The University of Sydney, Faculty of Medicine and Health, Sydney School of Public Health, Cancer Epidemiology and Prevention Research, Sydney, NSW, Australia. anne.cust@sydney.edu.au.
Pokaż więcej
Corporate Authors:
Managing Your Risk Study Group
Źródło:
Trials [Trials] 2020 Jun 30; Vol. 21 (1), pp. 594. Date of Electronic Publication: 2020 Jun 30.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Data Interpretation, Statistical*
Genetic Predisposition to Disease*
Genetic Testing/*economics
Genomics/*economics
Melanoma/*prevention & control
Skin Neoplasms/*prevention & control
Australia ; Cost-Benefit Analysis ; Environmental Exposure/prevention & control ; Health Behavior ; Humans ; Melanoma/economics ; Melanoma/genetics ; Melanoma/psychology ; Randomized Controlled Trials as Topic ; Risk Assessment ; Skin Neoplasms/economics ; Skin Neoplasms/genetics ; Skin Neoplasms/psychology ; Ultraviolet Rays/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Implementation considerations for offering personal genomic risk information to the public: a qualitative study.
Autorzy:
Smit AK; Faculty of Medicine and Health, Sydney School of Public Health, Cancer Epidemiology and Prevention Research, The University of Sydney, Sydney, Australia. .; Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Sydney, Australia. .; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. .
Reyes-Marcelino G; Faculty of Medicine and Health, Sydney School of Public Health, Cancer Epidemiology and Prevention Research, The University of Sydney, Sydney, Australia.
Keogh L; Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia.
Dunlop K; Faculty of Medicine and Health, Sydney School of Public Health, Cancer Epidemiology and Prevention Research, The University of Sydney, Sydney, Australia.
Newson AJ; Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Sydney, Australia.
Cust AE; Faculty of Medicine and Health, Sydney School of Public Health, Cancer Epidemiology and Prevention Research, The University of Sydney, Sydney, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2020 Jun 29; Vol. 20 (1), pp. 1028. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji:
Journal Article
MeSH Terms:
Genetic Testing*
Early Detection of Cancer/*psychology
Melanoma/*prevention & control
Patient Acceptance of Health Care/*psychology
Research Subjects/*psychology
Adult ; Aged ; Attitude ; Clinical Trials as Topic ; Communication ; Early Detection of Cancer/methods ; Emotions ; Female ; Genomics ; Humans ; Male ; Melanoma/genetics ; Middle Aged ; Pilot Projects ; Qualitative Research ; Risk Assessment ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.
Autorzy:
Guitera P; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Discipline of Dermatology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Collgros H; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Madronio CM; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Goumas C; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Mann GJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Watts CG; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Surveillance, Evaluation & Research Program, Kirby Institute, The University of New South Wales, Sydney, New South Wales, Australia.
Pereira AR; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.; Department of Dermatology, Federal University of Sao Paulo, Sao Paulo, Brazil.
Armstrong BK; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Drummond M; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Morton RL; NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia.
Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Discipline of Dermatology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Menzies SW; Discipline of Dermatology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Discipline of Surgery, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Cust AE; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2019 May; Vol. 60 (2), pp. 118-125. Date of Electronic Publication: 2018 Oct 09.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Hutchinson's Melanotic Freckle/*epidemiology
Melanoma/*epidemiology
Skin Neoplasms/*epidemiology
Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Australia/epidemiology ; Biopsy ; Female ; Head and Neck Neoplasms/epidemiology ; Humans ; Hutchinson's Melanotic Freckle/surgery ; Incidence ; Male ; Margins of Excision ; Melanoma/surgery ; Middle Aged ; Prospective Studies ; Referral and Consultation/statistics & numerical data ; Sex Distribution ; Skin Neoplasms/surgery
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.
Autorzy:
Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Shi Y; Biostatistics Shared Resource, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
Kanetsky PA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
Thomas NE; Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Luo L; Department of Internal Medicine, Division of Epidemiology, Biostatistics and Preventive Medicine, University of New Mexico Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA.
Corrales-Guerrero S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Cust AE; Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Camperdown, NSW, Australia.
Sacchetto L; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
Zanetti R; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
Rosso S; Piedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
Armstrong BK; School of Global and Population Health, The University of Western Australia, Perth, WA, Australia.
Dwyer T; Nuffield Department of Obstetrics and Gynecology, The George Institute for Global Health, University of Oxford, Oxford, UK.
Venn A; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Gallagher RP; Cancer Control Research, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
Gruber SB; USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Marrett LD; Prevention and Cancer Control, Cancer Care Ontario, Toronto, ON, Canada.
Anton-Culver H; Department of Epidemiology, School of Medicine, University of California at Irvine, Irvine, CA, USA.
Busam K; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Begg CB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Berwick M; Department of Internal Medicine, Division of Epidemiology, Biostatistics and Preventive Medicine, University of New Mexico Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA.
Pokaż więcej
Corporate Authors:
GEM Study Group; Department of Internal Medicine, Division of Epidemiology, Biostatistics and Preventive Medicine, University of New Mexico Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA.
Źródło:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2018 Mar; Vol. 31 (2), pp. 287-296. Date of Electronic Publication: 2017 Nov 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Predisposition to Disease*
Melanoma/*diagnosis
Melanoma/*genetics
Polymorphism, Single Nucleotide/*genetics
Receptors, Calcitriol/*genetics
Sunlight/*adverse effects
Female ; Haplotypes/genetics ; Humans ; Male ; Melanoma/pathology ; Risk Factors ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 42

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies